Cardinal Health is one of the world's largest pharmaceutical distributors and healthcare services companies and one of the world's leading healthcare companies.

Cardinal Health generated $222.6 billion in revenue in fiscal year 2025, operating as both a pharmaceutical distributor and a medical products manufacturer and distributor. The company's pharmaceutical and specialty solutions segment distributes branded and generic drugs to retail pharmacies, hospital systems, and mail order pharmacies. Cardinal Health's Global Medical Products and Distribution segment manufactures and distributes surgical and laboratory products under the Cardinal Health brand. The company announced the acquisition of Solaris Health — the country's leading urology management services organization — in 2025, extending its specialty healthcare services strategy beyond pure distribution.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.


Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and digital health platforms
• Latest products, programs, and service initiatives
• M&A and partnership activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management